Reaction
Foot Amputation reporting signals
As of the last recalculation, Foot Amputation appears in 1,441 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is CANAGLIFLOZIN (PRR 470.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Canagliflozin | 582 | 470.6 | 480.0 |
| Gentamicin | 12 | 13.4 | 13.4 |
| Insulin Glargine-Yfgn | 19 | 12.7 | 12.7 |
| Insulin Human | 30 | 11.1 | 11.1 |
| Gentamicin Sulfate | 12 | 11.1 | 11.1 |
| Insulin Aspart | 48 | 10.8 | 10.8 |
| Insulin Degludec | 16 | 9.9 | 10.0 |
| Empagliflozin | 44 | 9.7 | 9.7 |
| Patiromer | 9 | 9.4 | 9.4 |
| Ranolazine | 6 | 8.3 | 8.3 |
| Insulin Glargine | 118 | 7.4 | 7.4 |
| Dapagliflozin | 15 | 6.9 | 7.0 |
| Insulin Lispro | 49 | 5.3 | 5.3 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 4 | 5.2 | 5.2 |
| Agalsidase Beta | 3 | 4.7 | 4.7 |
| Cenegermin-Bkbj | 3 | 3.6 | 3.6 |
| Cinacalcet Hydrochloride | 7 | 2.2 | 2.2 |